Philip D. Hall

417 total citations
15 papers, 303 citations indexed

About

Philip D. Hall is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Philip D. Hall has authored 15 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Molecular Biology. Recurrent topics in Philip D. Hall's work include Chronic Lymphocytic Leukemia Research (2 papers), Innovations in Medical Education (2 papers) and Pharmaceutical Practices and Patient Outcomes (2 papers). Philip D. Hall is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Innovations in Medical Education (2 papers) and Pharmaceutical Practices and Patient Outcomes (2 papers). Philip D. Hall collaborates with scholars based in United States, United Kingdom and Australia. Philip D. Hall's co-authors include Thomas G. Olsen, Mark Fenster, Debra Frei‐Lahr, Ronald B. Gartenhaus, Arthur E. Frankel, J Black, Bayard L. Powell, Donald R. Fleming, Lawrence B. Afrin and Gerald Niedobitek and has published in prestigious journals such as Cancer, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Philip D. Hall

13 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip D. Hall United States 8 127 66 51 44 43 15 303
Guy Verfaillie Belgium 10 125 1.0× 109 1.7× 76 1.5× 16 0.4× 58 1.3× 29 407
Hillary Johnson United States 10 64 0.5× 133 2.0× 120 2.4× 82 1.9× 34 0.8× 27 389
Diana Deleanu Romania 12 58 0.5× 79 1.2× 44 0.9× 49 1.1× 25 0.6× 47 457
Milena Tocut Israel 6 97 0.8× 86 1.3× 65 1.3× 90 2.0× 18 0.4× 18 311
Eiichi Ishii Japan 11 65 0.5× 89 1.3× 70 1.4× 29 0.7× 21 0.5× 29 409
Giovanbattista Ippoliti Italy 11 120 0.9× 31 0.5× 40 0.8× 49 1.1× 30 0.7× 22 292
Ploysyne Rattanakaemakorn Thailand 10 70 0.6× 59 0.9× 30 0.6× 93 2.1× 76 1.8× 31 363
Mukul Aggarwal India 9 57 0.4× 28 0.4× 41 0.8× 40 0.9× 33 0.8× 66 277
Wen-Hsun Chang Taiwan 14 47 0.4× 76 1.2× 67 1.3× 55 1.3× 21 0.5× 45 629
Paul Mayor United States 10 133 1.0× 156 2.4× 69 1.4× 60 1.4× 42 1.0× 23 486

Countries citing papers authored by Philip D. Hall

Since Specialization
Citations

This map shows the geographic impact of Philip D. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. Hall more than expected).

Fields of papers citing papers by Philip D. Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip D. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. Hall. The network helps show where Philip D. Hall may publish in the future.

Co-authorship network of co-authors of Philip D. Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Philip D. Hall. A scholar is included among the top collaborators of Philip D. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip D. Hall. Philip D. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Hall, Philip D.. (2024). Efficacy and feasibility of the RADA16 self‐assembling peptide, PuraStat® for haemostasis in laparoscopic gynaecological surgery: A pilot study. Australian and New Zealand Journal of Obstetrics and Gynaecology. 64(4). 407–410.
2.
Hall, Philip D., Sarah McBane, Cynthia Moreau, et al.. (2019). The Report of the 2018-2019 Professional Affairs Standing Committee: The Role of Educators in Pharmacy Practice Transformation. American Journal of Pharmaceutical Education. 83(10). 7596–7596. 7 indexed citations
3.
Hall, Philip D., et al.. (2019). Blinatumomab: A Step Forward in the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia. 2 indexed citations
4.
Hall, Philip D., et al.. (2013). A Continuous Quality Improvement Program to Focus a College of Pharmacy on Programmatic Advancement. American Journal of Pharmaceutical Education. 77(6). 117–117. 9 indexed citations
5.
6.
Olsen, Thomas G., et al.. (2008). Shrinkage of cutaneous specimens: formalin or other factors involved?. Journal of Cutaneous Pathology. 35(12). 1093–1096. 94 indexed citations
7.
Frei‐Lahr, Debra, et al.. (2005). Treatment of Acute Myeloid Leukemia During the Second and Third Trimesters of Pregnancy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(8). 1134–1140. 36 indexed citations
8.
Frankel, Arthur E., Donald R. Fleming, Philip D. Hall, et al.. (2003). A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia.. PubMed. 9(10 Pt 1). 3555–61. 60 indexed citations
9.
Hall, Philip D., et al.. (2002). Fentanyl‐Associated Syndrome of Inappropriate Antidiuretic Hormone Secretion. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(9). 1188–1192. 19 indexed citations
10.
11.
McClay, Edward F., et al.. (1997). A Phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma. Cancer. 79(5). 1037–1043. 17 indexed citations
12.
Hall, Philip D., et al.. (1997). Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration. American Journal of Health-System Pharmacy. 54(2). 185–189.
13.
Niedobitek, Gerald, Lawrence S. Young, Hermann Herbst, et al.. (1993). Overexpression of p53 in Hodgkin's disease: Lack of correlation with Epstein–Barr virus infection. The Journal of Pathology. 169(2). 207–212. 32 indexed citations
14.
Collins, C.M.P., et al.. (1993). Verapamil enhances doxorubicin activity in cultured human renal carcinoma cells. European Journal of Cancer. 29(3). 378–383. 7 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guy Verfaillie Breakdown of academic impact, for papers by Hillary Johnson Breakdown of academic impact, for papers by Diana Deleanu Breakdown of academic impact, for papers by Milena Tocut Breakdown of academic impact, for papers by Eiichi Ishii Breakdown of academic impact, for papers by Giovanbattista Ippoliti Breakdown of academic impact, for papers by Ploysyne Rattanakaemakorn Breakdown of academic impact, for papers by Mukul Aggarwal Breakdown of academic impact, for papers by Wen-Hsun Chang Breakdown of academic impact, for papers by Paul Mayor
Rankless by CCL
2026